EVE Health Group Ltd

NEW
ASX:EVE (Australia)  
A$ 0.019 (0%) Jul 3
At Loss
P/B:
1.46
Market Cap:
A$ 6.69M ($ 4.64M)
Enterprise V:
A$ 5.80M ($ 4.03M)
Volume:
14.20K
Avg Vol (2M):
373.74K
Trade In:
Volume:
14.20K
At Loss
Avg Vol (2M):
373.74K

Business Description

Description
EVE Health Group Ltd is an integrated Health, Nutrition, and Wellness investment company. The company operates in two reporting segments, namely Meluka (branded wellness consumer products) and Nextract.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
23.85
Equity-to-Asset
0.92
Debt-to-Equity
0.01
Debt-to-EBITDA
-0.02
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-5.82
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
21.57
9-Day RSI
28.07
14-Day RSI
32.22
3-1 Month Momentum %
8.7
6-1 Month Momentum %
25
12-1 Month Momentum %
-24.24

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
3.47
Quick Ratio
3.15
Cash Ratio
3.02
Days Inventory
84.49
Days Sales Outstanding
36.12
Days Payable
151.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-2.9
Shareholder Yield %
-14.05

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
48.79
Operating Margin %
-119.54
Net Margin %
-119.1
EBITDA Margin %
-119.1
FCF Margin %
-113.45
OCF Margin %
-113.3
ROE %
-62.92
ROA %
-53.45
ROIC %
-77.41
3-Year ROIIC %
-89.31
ROC (Joel Greenblatt) %
-1744.09
ROCE %
-62.96

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio
2.71
PB Ratio
1.46
EV-to-EBIT
-3.58
EV-to-EBITDA
-3.58
EV-to-Revenue
4.26
EV-to-FCF
-3.76
Price-to-GF-Value
1.9
Earnings Yield (Greenblatt) %
-27.93
FCF Yield %
-23.07

Financials

ASX:EVE's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

EVE Health Group Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 1.361
EPS (TTM) (A$) -0.007
Beta 0.3869
3-Year Sharpe Ratio -0.38
3-Year Sortino Ratio -0.6
Volatility % 68.68
14-Day RSI 32.22
14-Day ATR (A$) 0.001325
20-Day SMA (A$) 0.021025
12-1 Month Momentum % -24.24
52-Week Range (A$) 0.017 - 0.036
Shares Outstanding (Mil) 352.33

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

EVE Health Group Ltd Filings

Filing Date Document Date Form
No Filing Data

EVE Health Group Ltd Stock Events

Financials Calendars
Event Date Price (A$)
0.025:1 Stock Split 2025-06-02 0.04 (+0.00%)
Show
Entries

EVE Health Group Ltd Frequently Asked Questions

What is EVE Health Group Ltd(ASX:EVE)'s stock price today?
The current price of ASX:EVE is A$0.02. The 52 week high of ASX:EVE is A$0.04 and 52 week low is A$0.02.
When is next earnings date of EVE Health Group Ltd(ASX:EVE)?
The next earnings date of EVE Health Group Ltd(ASX:EVE) is .
Does EVE Health Group Ltd(ASX:EVE) pay dividends? If so, how much?
EVE Health Group Ltd(ASX:EVE) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on EVE Health Group Ltd

No articles.